Publication | Open Access
BET protein bromodomain inhibitor-based combinations are highly active against post-myeloproliferative neoplasm secondary AML cells
89
Citations
36
References
2016
Year
Hematological MalignancyInhibitor-based CombinationsBet ProteinMixed-phenotype Acute LeukemiaMalignant Blood DisorderImmunologyImmunotherapyMedicineCell BiologyTumor BiologyMyeloid Neoplasia
| Year | Citations | |
|---|---|---|
Page 1
Page 1